Compare Compass Inc. Class A Common Stock (COMP) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Compass Inc. Class A Common Stock vs Relay Therapeutics Inc. Common Stock — how do they compare? Compass Inc. Class A Common Stock trades at $9.52 (market cap $7.05B), while Relay Therapeutics Inc. Common Stock trades at $17.39 (market cap $3.94B). The key difference: Compass Inc. Class A Common Stock is the larger of the two by market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, Compass Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Compass Inc. Class A Common Stock for 0 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| COMP | RLAY | |
|---|---|---|
Market Cap | $7.05B | $3.94B |
Volume | 15,310,192 | 3,432,928 |
Sector | Real Estate | Health |
52-Week High | $13.58 | $20.75 |
52-Week Low | $6.68 | $6.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.47B | $3.06B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Compass Inc. Class A Common Stock
Compass is a technology-enabled residential real estate company. Its platform provides agents with tools for customer relationships, marketing, client service, and transactions, alongside brokerage, title, escrow, and mortgage services.
Read more on COMP →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
